Skip to main navigation
Ventyx Biosciences, Inc. Ventyx Biosciences, Inc.
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Advisory Board
    • Contact
  • Science
  • Pipeline
    • Overview
    • VTX958
    • VTX002
    • VTX2735
    • VTX3232
  • Investors
    • Overview
    • News & events
    • Stock information
    • Governance
    • Financials & filings
    • IR resources
  • Careers
  • News Releases
  • Events
  • Presentations

News Releases

News Releases

May 9, 2022
Ventyx Biosciences Announces Appointment of William Sandborn, MD, as President and Chief Medical Officer
Read more
May 5, 2022
Ventyx Biosciences to Report First Quarter 2022 Financial Results on May 12, 2022
Read more
March 23, 2022
Ventyx Biosciences Reports Full Year 2021 Financial Results and Highlights Recent Corporate Progress
Read more
March 7, 2022
Ventyx Biosciences to Participate in the Barclays Global Healthcare Conference
Read more
December 6, 2021
Ventyx Biosciences Announces First Patient Dosed in a Phase 2 Clinical Trial of VTX002 for the Treatment of Moderate-to-Severe Ulcerative Colitis
Read more
November 19, 2021
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
Read more
November 17, 2021
Ventyx Biosciences Reports Third Quarter Financial Results and Provides Business Update
Read more
October 25, 2021
Ventyx Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read more
October 20, 2021
Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering
Read more
September 20, 2021
Ventyx Biosciences Announces Key Appointments and Closing of $51.0 Million Series B Convertible Preferred Stock Financing Round
Read more
  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
Displaying 31 - 40 of 40


Email Alerts


FAQ


Contact IR


RSS Feeds
Contact us
info@ventyxbio.com
  • Privacy Policy
  • Terms Of Use
© 2023 Ventyx Biosciences, Inc. All rights reserved.
linkedin
Ventyx Biosciences, Inc.